EUVIMEDEUVIMED entdecken
Crossref

Low-Dose Rivaroxaban, Cardiovascular Events, and Kidney Disease—Reply

Sunil V Badve, An S De Vriese, Martin Gallagher

JAMA · 03.11.2026 · 336 (17) · 1568

DOI: 10.1001/jama.2026.16113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 03.11.2026. Verfasst von Sunil V Badve und 2 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Department of Renal Medicine, St George Hospital, Sydney, New South Wales, Australia.
  • Division of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge, Brugge, Belgium.
  • Department of Internal Medicine, Ghent University, Ghent, Belgium.
  • University of New South Wales, Sydney, New South Wales, Australia.

Zitieren

APA

Badve, S. V., De Vriese, A. S., & Gallagher, M. (2026). Low-Dose Rivaroxaban, Cardiovascular Events, and Kidney Disease—Reply. JAMA, 336(17), 1568. https://doi.org/10.1001/jama.2026.16113

Vancouver

Badve SV, De Vriese AS, Gallagher M. Low-Dose Rivaroxaban, Cardiovascular Events, and Kidney Disease—Reply. JAMA. 2026;336(17):1568. doi:10.1001/jama.2026.16113

BibTeX
@article{Badve2026,
  author = {Badve, Sunil V and De Vriese, An S and Gallagher, Martin},
  title = {Low-Dose Rivaroxaban, Cardiovascular Events, and Kidney Disease—Reply},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {17},
  pages = {1568},
  doi = {10.1001/jama.2026.16113}
}
Kostenlos starten →